NCT00588874 is a clinical trial in Low Bone Density, sponsored by Yale University.

Who is sponsoring NCT00588874?

NCT00588874 is sponsored by Yale University.

What condition does NCT00588874 study?

NCT00588874 studies Low Bone Density.

Is NCT00588874 still recruiting?

NCT00588874 is currently completed. Last updated 30 August 2023.

Last reviewed 2023-08-30 · How we verify

NCT00588874

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Age Related Changes in Calciotropic Hormones and Their Impact on Male Osteoporosis

Completed Last updated 30 August 2023

What this trial tests

trial in Low Bone Density in 24 participants. Completed in 1 December 2008.

Timeline

1 October 2000

Primary endpoint
1 July 2002

1 December 2008

Quick facts

Lead sponsor	Yale University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	24
Start date	1 October 2000
Primary completion	1 July 2002
Estimated completion	1 December 2008
Sites	1 location across United States

Conditions studied

Low Bone Density — all drugs for Low Bone Density →

Sponsor

Yale University

Who can join

50 and older, male only, with Low Bone Density. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this pilot study is to generate preliminary data regarding the skeletal effects of age-related changes in calcium and vitamin D metabolism in older men.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Low Bone Density

Currently open trials in the same condition.

NCT05283148 — Sickle Cell Disease (SCD) Bone Pain Study · NA · active not recruiting

Other Yale University trials

Trials by the same sponsor.

NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking · Phase 2 · not yet recruiting
NCT04910984 — Developing a Chatbot to Promote HIV Testing · NA · not yet recruiting
NCT07458087 — Accuracy of the Accuro 3S · NA · not yet recruiting
NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa · Phase 1, PHASE2 · not yet recruiting
NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00588874 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yale University
Last refreshed: 30 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00588874.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing